Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Shares Issued (2016 - 2025)

Historic Shares Issued for Anterix (ATEX) over the last 12 years, with Q3 2025 value amounting to $157000.0.

  • Anterix's Shares Issued fell 5422.74% to $157000.0 in Q3 2025 from the same period last year, while for Dec 2025 it was $1.8 million, marking a year-over-year decrease of 3230.77%. This contributed to the annual value of $3.7 million for FY2025, which is 36988.42% up from last year.
  • Latest data reveals that Anterix reported Shares Issued of $157000.0 as of Q3 2025, which was down 5422.74% from $1.7 million recorded in Q1 2025.
  • Anterix's Shares Issued's 5-year high stood at $5.4 million during Q2 2021, with a 5-year trough of $7000.0 in Q2 2023.
  • Over the past 5 years, Anterix's median Shares Issued value was $1.1 million (recorded in 2022), while the average stood at $1.7 million.
  • As far as peak fluctuations go, Anterix's Shares Issued crashed by 9919.72% in 2023, and later surged by 2300000.0% in 2024.
  • Over the past 5 years, Anterix's Shares Issued (Quarter) stood at $3.6 million in 2021, then tumbled by 75.9% to $872000.0 in 2022, then plummeted by 99.2% to $7000.0 in 2023, then soared by 4800.0% to $343000.0 in 2024, then tumbled by 54.23% to $157000.0 in 2025.
  • Its last three reported values are $157000.0 in Q3 2025, $1.7 million for Q1 2025, and $343000.0 during Q3 2024.